文献速递肝病

血管性血友病因子延缓对乙酰氨基酚诱导的小鼠急性肝损伤后肝脏修复

Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice.
PubMed 文献 · J Hepatol · 2019-10-10

该研究在小鼠中探讨血管性血友病因子(VWF)在对乙酰氨基酚(APAP)诱导的急性肝损伤中的作用。野生型与VWF缺陷小鼠接受肝毒性剂量APAP(300 mg/kg,腹腔注射)后,VWF缺陷或阻断VWF/血小板整合素αIIbβ3可减少肝内血小板聚集并加速肝脏修复。提示靶向VWF可能成为改善APAP肝损伤修复的新策略。

要点

  • APAP过量后野生型小鼠血浆VWF水平、高分子量VWF多聚体和VWF活性在24小时下降,48小时血浆VWF水平升高但高分子量多聚体和活性相对降低。
  • VWF缺陷对APAP诱导的肝损伤峰值和肝内血小板聚集峰值影响不大,但48小时时Vwf-/-小鼠肝内血小板几乎缺失,肝脏修复显著加速。
  • 在野生型小鼠损伤发展期阻断VWF或血小板整合素αIIbβ3,可显著减少肝内血小板聚集并加速肝脏修复。

核心结论

  • VWF与APAP诱导的急性肝损伤后肝内血小板聚集及肝脏修复存在机制关联,靶向VWF可能改善肝脏修复。

研究设计与样本

  • 野生型小鼠与VWF缺陷(Vwf-/-)小鼠接受肝毒性剂量APAP(300 mg/kg,腹腔注射)或生理盐水对照。
  • 采用ELISA检测血浆VWF水平,免疫组化检测肝坏死或肝细胞增殖,免疫荧光检测血小板与VWF沉积。

主要发现

  • 野生型小鼠APAP后24小时血浆VWF水平、高分子量VWF多聚体和VWF活性下降,伴肝内VWF和血小板大量沉积。
  • VWF缺陷对APAP后肝内血小板聚集峰值或肝损伤峰值影响甚微。
  • APAP后48小时野生型小鼠血浆VWF水平升高,但高分子量多聚体和VWF活性相对降低。
  • APAP后48小时野生型小鼠肝内血小板聚集体持续存在,而Vwf-/-小鼠肝内血小板几乎缺失,且肝脏修复显著加速。
  • 在野生型小鼠损伤发展期阻断VWF或血小板整合素αIIbβ3,可显著减少肝内血小板聚集并加速肝脏修复。

临床怎么用

  • 在APAP诱导的急性肝损伤中,靶向VWF或血小板整合素αIIbβ3可能加速肝脏修复,但本研究仅为小鼠实验,尚未在临床验证。

局限性

  • 研究仅在小鼠中进行,结论外推至人类需进一步临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIM: Acetaminophen (APAP)-induced acute liver failure is associated with substantial alterations in the hemostatic system. In mice, platelets accumulate in the liver after APAP overdose and appear to promote liver injury. Interestingly, patients with acute liver injury have highly elevated levels of the platelet-adhesive protein von Willebrand factor (VWF), but a mechanistic connection between VWF and progression of liver injury has not been established. We tested the hypothesis that VWF contributes directly to experimental APAP-induced acute liver injury. METHODS: Wild-type mice and VWF-deficient (Vwf-/-) mice were given a hepatotoxic dose of APAP (300 mg/kg, i.p.) or vehicle (saline). VWF plasma levels were measured by ELISA, and liver necrosis or hepatocyte proliferation was measured by immunohistochemistry. Platelet and VWF deposition were measured by immunofluorescence. RESULTS: In wild-type mice, VWF plasma levels, high molecular weight (HMW) VWF multimers, and VWF activity decreased 24 h after APAP challenge. These changes coupled to robust hepatic VWF and platelet deposition, although VWF deficiency had minimal effect on peak hepatic platelet accumulation or liver injury. VWF plasma levels were elevated 48 h after APAP challenge, but with relative reductions in HMW multimers and VWF activity. Whereas hepatic platelet aggregates persisted in livers of APAP-challenged wild-type mice, platelets were nearly absent in Vwf-/- mice 48 h after APAP challenge. The absence of platelet aggregates was linked to dramatically accelerated repair of the injured liver. Complementing observations in Vwf-/- mice, blocking VWF or the platelet integrin αIIbβ3 during development of injury significantly reduced hepatic platelet aggregation and accelerated liver repair in APAP-challenged wild-type mice. CONCLUSION: These studies are the first to suggest a mechanistic link between VWF, hepatic platelet accumulation, and liver repair. Targeting VWF might provide a novel therapeutic approach to improve repair of the APAP-injured liver. LAY SUMMARY: Patients with acute liver injury due to acetaminophen overdose have highly elevated levels of the platelet-adhesive protein von Willebrand factor. It is not known whether von Willebrand factor plays a direct role in the progression of acute liver injury. We discovered that von Willebrand factor delays repair of the acetaminophen-injured liver in mice and that targeting von Willebrand factor, even in mice with established liver injury, accelerates liver repair.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Groeneveld D, Cline-Fedewa H, Baker KS, et al. Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice. J Hepatol. 2019. PMID: 31606553. doi:10.1016/j.jhep.2019.09.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。